Academic rejects ‘fuzzy math’ claim in spat over curcumin bioavailability
The authors of a recent study into curcumin bioavailability have rejected claims by a cancer researcher that “fuzzy math” led them to overestimate the absorption of the anti-inflammatory agent curcumin from some supplement formulations.